STAT3 and rheumatoid arthritis: Increased utilization of T-cell clonality and STAT3 mutational profiling may lead to increased diagnosis of LGL leukemia within RA and FS patient populations, yet these events are likely detectable in all three diseases with ultrasensitive detection methods.